Inventor

THORSETT EUGENE D

US106 patents

⚠️ This page may combine multiple inventors who share the name “THORSETT EUGENE D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THORSETT EUGENE D

ELAN PHARM INC

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.

Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

Inhibitors of leukocyte adhesion

Arylsulfonamides as phospholipase A2 inhibitors

Succinoyl aminopyrazoles and related compounds

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

Sulfonylquinoxalone derivatives as bradykinin antagonists

MERCK & CO INC

Bicyclic lactams

Carbapenem antibacterial agents

Benzofused lactams as antihypertensives

Substituted phosphonamides as antihypertensives

Aminoacid derivatives as antihypertensives

Substituted caprolactam derivatives as antihypertensives

Substituted caprylolactam derivatives as anti-hypertensives

Substituted enantholactam derivatives as antihypertensives

Substituted caprolactam derivatives as antihypertensives

ATHENA NEUROSCIENCES INC

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4

N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use

N-(aryl/heteroaryl) amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4

4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

WYETH CORP

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrins

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

(unassigned)

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Substituted 3-indolyl-5-pyrazolone compounds

GENENTECH INC

Cyclized peptides and their use as platelet aggregation inhibitors

LILLY CO ELI

Lactam compound